Abstract

This study aimed to examine out-of-pocket expenditure for cancer treatments of hospitalized patients and to analyze changing patterns over time. This study examined data of all cancer patients receiving inpatient care from two tertiary hospitals from January 2003 to December 2010. Medical expenditures per admission were calculated and classified into those covered and uncovered by the Korean National Health Insurance (NHI) and co-payment. The medical expenditure per admission increased slowly from 3,455 thousand Korean won (KRW) to 4,068 thousand KRW. While expenditures covered by the NHI have increased annually, co-payments have generally decreased. The out-of-pocket expenditure ratio, which means the proportion of uncovered expenditure and co-payment among total medical expenditure dropped sharply from 2005 to 2007 and was maintained at a similar level after 2007. Medical expenditures, NHI coverage, and the out-of-pocket expenditure ratio differed across cancer types. It is necessary to continually monitor the expenditure of uncovered services by the NHI, and to provide policies to reduce this economic burden. In addition, an individual approach considering cancer type-specific characteristics and medical utilization should be provided.

Highlights

  • Cancer has remained the primary cause of death over the last 30 years in Korea, and the incidence of cancer is continually increasing

  • Subjects In order to validate the trends in hospital medical expenditure incurred by cancer treatments, this study examined all cancer patients who received inpatient care at two academic medical centers located in Seoul, Korea from January 1, 2003 to December 31, 2010

  • This study showed that the number of cancer patients receiving inpatient care in the two hospitals sharply increased from 17,160 in 2003 to 35,127 in 2010

Read more

Summary

Introduction

Cancer has remained the primary cause of death over the last 30 years in Korea, and the incidence of cancer is continually increasing. According the Korean National Health Insurance (NHI) statistics, the amount of benefit caused by the diagnosis of neoplasm (ICD C00-D48) was 2,626 billion Korean won (KRW) (2,826 million US dollars) in 2007. This accounted for 10.7% of the total annual benefits of NHI in 2007. In 2011, the amount of benefits due cancer increased to 4,601 billion KRW (4,152 million US dollars) and the percentage of the total annual benefits increased to 12.8% (National Health Insurance Service, 2013). Medical expenditures per admission were calculated and classified into those covered and uncovered by the Korean National Health Insurance (NHI) and co-payment. An individual approach considering cancer type-specific characteristics and medical utilization should be provided

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call